You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High-dose radiotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Liver Metastases Trial in Nanjing (Radiation: High- and Low-dose radiotherapy, PD-1 Inhibitors)

Recruiting
  • Colorectal Liver Metastases
  • Radiation: High- and Low-dose radiotherapy
  • PD-1 Inhibitors
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Sep 13, 2023

Chemotherapy Combined With High-dose Radiotherapy for Low Rectal

Recruiting
  • Rectal Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 9, 2022

Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)

Recruiting
  • Microsatellite Stable Metastatic Colorectal Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 19, 2023

Metastatic Cancer Trial in Nanchang (High- and Low-dose radiotherapy)

Recruiting
  • Metastatic Cancer
  • High- and Low-dose radiotherapy
  • Nanchang, Jiangxi, China
  • +1 more
Mar 6, 2023

Cervical Tumor, Adaptive Radiotherapy, Radiotherapy; Adverse Effect Trial in Beijing (Moderately hypofractionated adaptive

Recruiting
  • Cervical Neoplasm
  • +2 more
  • Moderately hypofractionated adaptive radiotherapy (ART)+ High-dose rate (HDR) Brachytherapy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 15, 2023

Early Lung Cancer, Stereotactic Body Radiotherapy Trial in Peking (SBRT)

Not yet recruiting
  • Early Lung Cancer
  • Stereotactic Body Radiotherapy
  • SBRT
  • Peking, Beijing, China
    Department of radiation oncology, Peking University Third Hospit
Mar 26, 2023

Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in Lausanne (FLASH RT, Conventional RT)

Not yet recruiting
  • Basal Cell Carcinoma
  • Cutaneous Squamous Cell Carcinoma
  • FLASH RT
  • Conventional RT
  • Lausanne, Vaud, Switzerland
    Centre Hospitalier Universitaire Vaudois (CHUV)
Feb 13, 2023

Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in New Brunswick,

Recruiting
  • Stage I Prostate Cancer AJCC v8
  • +4 more
  • High-Dose Rate Brachytherapy
  • +3 more
  • Livingston, New Jersey
  • +2 more
Oct 6, 2022

Prostate Cancer, Radiotherapy Side Effect Trial (Brachytherapy, Sterotactic Body Radiotherapy)

Not yet recruiting
  • Prostate Cancer
  • Radiotherapy Side Effect
  • Brachytherapy
  • Sterotactic Body Radiotherapy
  • (no location specified)
Nov 14, 2022

Early Metastasis in Cervical Cancer Patients After Radiotherapy

Not yet recruiting
  • Cervical Cancer
  • +4 more
  • external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT)
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Oct 21, 2023

Percutaneous High-dose Radiotherapy in Oligometastases of

Completed
  • Oligometastatic Disease
  • Prostate Cancer
  • normal fractionated irradiation
  • hypo fractionated irradiation
  • Dresden, Saxony, Germany
  • +1 more
Aug 18, 2021

Squamous Cell Carcinoma of the Head and Neck Trial (Xevinapant, Placebo, cetuximab)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • (no location specified)
Jul 3, 2023

Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC

Recruiting
  • Prostate Adenocarcinoma
  • +7 more
  • High-Dose Rate Brachytherapy
  • Stereotactic Body Radiation Therapy
  • Los Angeles, California
    University of California at Los Angeles / Jonsson Comprehensive
Oct 13, 2022

Cancer of Rectum Trial in Denmark (50.4 Gy to the tumor and elective volume, 62 Gy to the clinical tumor volume and 50.4 Gy to

Recruiting
  • Cancer of Rectum
  • 50.4 Gy to the tumor and elective volume
  • +2 more
  • Aalborg, Denmark
  • +4 more
May 24, 2022

Non Small Cell Lung Cancer Trial in Sweden (Standard systemic therapy + radiotherapy, Standard systemic therapy)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Standard systemic therapy + radiotherapy
  • Standard systemic therapy
  • Gothenburg, Sweden
  • +5 more
Nov 17, 2023

Objective Response Rate Trial in Wuhan (GM-CSF)

Recruiting
  • Objective Response Rate
  • Wuhan, Hubei, China
    Renmin Hospital of Wuhan University
Feb 25, 2023

Nasopharyngeal Carcinoma, De-escalation Therapy Trial in Guangzhou (Cisplatin-based induction chemo, Full course of PD-1/PD-L1

Recruiting
  • Nasopharyngeal Carcinoma
  • De-escalation Therapy
  • Cisplatin-based induction chemotherapy
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 16, 2023

Oropharyngeal Squamous Cell Carcinoma Trial in Chicago (Transoral Robotic Surgery (TORS) or Radiotherapy, Chemotherapy and

Recruiting
  • Oropharyngeal Squamous Cell Carcinoma
  • Transoral Robotic Surgery (TORS) or Radiotherapy
  • +4 more
  • Chicago, Illinois
    University of Chicago Medical Center
Nov 12, 2021

Head Neck Cancer Trial in Worldwide (cisplatinum, Conventional radiotherapy, Adaptive radiotherapy)

Active, not recruiting
  • Head and Neck Cancer
  • Villejuif, France
  • +8 more
Sep 27, 2022

Hepatocellular Carcinoma Trial in France (TACE, TACE+ RTC)

Completed
  • Hepatocellular Carcinoma
  • TACE
  • TACE+ RTC
  • Amiens, France
  • +17 more
Dec 23, 2021

Glioblastoma Multiforme, Adult, Glioblastoma, IDH-mutant Trial (Dose escalation + Reduced Margin Adaptive Radiotherapy)

Not yet recruiting
  • Glioblastoma Multiforme, Adult
  • Glioblastoma, IDH-mutant
  • Dose escalation + Reduced Margin Adaptive Radiotherapy
  • (no location specified)
Oct 3, 2022

Locally Advanced Malignant Tumor, Inflammatory Breast Carcinoma, Triple-Negative Invasive Breast Carcinoma Trial in Amsterdam

Completed
  • Locally Advanced Malignant Neoplasm
  • +2 more
  • Amsterdam, Netherlands
    The Netherlands Cancer Institute
Aug 3, 2021

Prostate Cancer Trial in New York (Dose escalation)

Recruiting
  • Prostate Cancer
  • Dose escalation
  • New York, New York
    Weill Cornell Medicine
Jul 29, 2022

ABlative Radiotherapy (for) Unfavorable Prostate Tumors

Recruiting
  • Prostate Cancer
    • Monza, MB, Italy
      Radiation Oncology, ASST Monza (University of Milan Bicocca)
    Jul 21, 2022

    Non Small Cell Lung Cancer Stage III Trial in Melbourne (Functionally adapted, dose escalated VMAT radiotherapy)

    Completed
    • Non Small Cell Lung Cancer Stage III
    • Functionally adapted, dose escalated VMAT radiotherapy
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    May 17, 2022